GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **601 - 625** of **4050** in total

« First

‹ Prev

…

21

22

23

24

25

26

27

28

29

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 2	15	mild	G17266GE	41
IgG	Patient 2	15	mild	G58547FH	41
IgG	Patient 2	24	mild	G25473LQ	41
IgG	Patient 2	24	mild	G29857RC	41
IgM	Patient 2	15	mild	G00051MO	41
IgG	Patient 2	3	mild	G19868AX	41
IgG	Patient 2	3	mild	G43648DB	41
IgG	Patient 3	-180	mild	G67045LB	41
IgG	Patient 3	-180	mild	G86566MF	41
IgG	Patient 3	-180	mild	G89993FE	41
IgG	Patient 3	11	mild	G61751GZ	41
IgG	Patient 3	4	mild	G00051MO	41
IgG	Patient 3	4	mild	G00054MO	41
IgG	Patient 3	4	mild	G25407RZ	41
IgG	Patient 4	12	mild	G57449OF	41
IgG	Patient 1	22	moderate	G09609EN	42
IgG	Patient 1	22	moderate	G22768VO	42
IgG	Patient 1	22	moderate	G82942ZJ	42
IgG	Patient 1	22	moderate	G96557TJ	42
IgG	Patient 1	6	moderate	G32473MI	42
IgM	Patient 1	10	moderate	G21320TF	42
IgG	Patient 1	6	moderate	G47566FL	42
IgM	Patient 1	6	moderate	G00065MO	42
IgM	Patient 1	6	moderate	G14988WV	42
IgM	Patient 1	6	moderate	G72739GY	42